Candida Albicans Patents (Class 435/922)
  • Patent number: 7090857
    Abstract: The present invention relates to antigenic preparations comprising polysaccharides and/or glycopeptides preparable from keratinophilic fungi as well as yeasts, process for the preparation of these antigenic preparations, their use as pharmaceutical substances as well as their use as vaccines, including but not limited to, the prophylaxis and treatment of allergy, as well as for modulating the immune response.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: August 15, 2006
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Dieter Farnow, Joachim Karle, Igor D. Poliakov, Ludmilla G. Ivanova
  • Patent number: 7001776
    Abstract: This invention provides a novel device and method for preparing cytology slides. The device comprises a book-like form including an absorbent material and filter attached to the inside surface of a front cover and a cytology slide removeably attached to an inside surface of a back cover. A sample is removed from the body of a patient, placed in a liquid-based solution, and then on the filter. When the book-like form is closed, the sample is effectively transferred to the slide. The device can be modified so that a plurality of slides are prepared at the same time.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: February 21, 2006
    Assignee: Digene Corporation
    Inventors: Gerson Botacini das Dores, Iwona Mielzynska-Lohnas, Eliane Taromaru, William J. Payne, Joseph P. Slattery, James G. Lazar
  • Patent number: 6890729
    Abstract: This invention provides a novel device and method for preparing cytology slides. The device comprises a book-like form including an absorbent material and filter attached to the inside surface of a front cover and a cytology slide removeably attached to an inside surface of a back cover. A sample is removed from the body of a patient, placed in a liquid-based solution, and then on the filter. When the book-like form is closed, the sample is effectively transferred to the slide.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: May 10, 2005
    Assignee: Digene Corporation
    Inventors: Iwona Mielzynska, Jay Payne, James Lazar
  • Patent number: 6627408
    Abstract: The present invention provides high throughput screening Systems for identifying antifungal compounds. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
    Type: Grant
    Filed: October 11, 2002
    Date of Patent: September 30, 2003
    Assignee: Cytokinetics, Inc.
    Inventors: Corey E. Nislow, Roman Sakowicz, Christophe Beraud
  • Patent number: 6468760
    Abstract: The present invention provides high throughput screening systems for identifying antifungal compounds. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: October 22, 2002
    Assignee: Cytokinetics, Inc.
    Inventors: Corey E. Nislow, Roman Sakowicz, Christophe Beraud
  • Patent number: 6436662
    Abstract: This invention provides a novel device and method for preparing cytology slides. The device comprises a book-like form including an absorbent material and filter attached to the inside surface of a front cover and a cytology slide removeably attached to an inside surface of a back cover. A sample is removed from the body of a patient, placed in a liquid-based solution, and then on the filter. When the book-like form is closed, the sample is effectively transferred to the slide.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: August 20, 2002
    Assignee: Digene Corporation
    Inventors: Iwona Mielzynska, Jay Payne, James Lazar
  • Patent number: 6379678
    Abstract: The present invention relates to antigenic preparations comprising polysaccharides and/or glycopeptides preparable from keratinophilic fungi as well as yeasts, processes for the preparation of these antigenic preparations, their use as pharmaceutical substances as well as their use as vaccines, including but not limited to, the prophylaxis and treatment of allergy, as well as for modulating the immune response.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: April 30, 2002
    Assignee: Boehringer Indgelheim Vetmedica GmbH
    Inventors: Dieter Farnow, Joachim Karle, Igor D. Poliakov, Ludmilla G. Ivanova
  • Patent number: 6333164
    Abstract: There can be provided a fungal antigen which is an insoluble fraction obtainable from fungal cells of which cell wall has been substantially removed or at least partially removed; a process for producing the same; a nucleic acid encoding the fungal antigen; a biologic product containing the fungal antigen; a method of stimulating immunological responses by using the biologic product; a method of suppressing allergic reaction to fungi in a vertebrate; and a method for diagnosing a disease caused by fungi in a vertebrate.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: December 25, 2001
    Assignee: Takara Shuzo Co., Ltd.
    Inventors: Kazutoh Takesako, Shigetoshi Mizutani, Masahiro Endo, Ikunoshin Kato
  • Patent number: 6300140
    Abstract: A slide having a portion thereof provided with transparent adhesive which adheres to a test sample. The slide and adhesive may be transparent. Specific types of infection and particularly fungal infections can be detected in the test sample using immunotest-methods. In a special embodiment the adhesive slide is fashioned with a peripheral lip or well to contain a test sample and a reagent.
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: October 9, 2001
    Assignee: Leonard Bloom
    Inventors: Howard N. Robinson, Francisco A. Tausk, Bruce S. Bochner, Neil F. Martin
  • Patent number: 6284480
    Abstract: The present invention provides high throughput screening systems for identifying antifungal compounds. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: September 4, 2001
    Assignee: Cytokinetics, Inc.
    Inventors: Corey E. Nislow, Roman Sakowicz, Christophe Beraud
  • Patent number: 6136953
    Abstract: A substantially pure DNA comprising a sequence encoding a smooth muscle cell LIM (SmLIM) polypeptide, methods of diagnosing vascular injury by detecting a decrease in SmLIM gene expression, and methods of inhibiting vascular smooth muscle cell proliferation.
    Type: Grant
    Filed: April 2, 1998
    Date of Patent: October 24, 2000
    Assignee: President and Fellows of Harvard College
    Inventors: Mu-En Lee, Edgar Haber, Mukesh Jain, Shaw-Fang Yet
  • Patent number: 5998181
    Abstract: The present invention relates to a fermentation process for preparing xylitol with high productivity and high yield using a novel strain of Candida tropicalis, more specifically, for preparing xylitol under optimal fermentation conditions for maximum xylitol production by optimizing the composition of medium containing xylose and the environmental conditions of culture such as pH, temperature and DO concentration.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: December 7, 1999
    Assignee: Bolak Co., Ltd.
    Inventors: Sang Yong Kim, Deok Kun Oh, Soo Ryun Jung
  • Patent number: 5994149
    Abstract: A slide having a portion thereof provided with transparent adhesive which adheres to a test sample. The slide and adhesive may be transparent. Specific types of infection and particularly fungal infections can be detected in the test sample using immunotest-methods. In a special embodiment the adhesive slide is fashioned with a peripheral lip or well to contain a test sample and a reagent.
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: November 30, 1999
    Assignee: Leonard Bloom
    Inventors: Howard N. Robinson, Francisco Tausk, Bruce Bochner, Neil F. Martin
  • Patent number: 5789191
    Abstract: The invention provides a cosmetic or dermatological method for detecting and/or selectively quantifying individual microorganisms, and/or whole groups of microorganisms, which are present on human or animal skin, comprising the steps ofremoving a sample of the microflora of the human or animal skin,treating the sample with a deinhibiting medium, adding the treated sample to a culture medium which exhibits favorable growth conditions for a defined group of microorganisms but unfavorable growth conditions for other microorganisms, to produce a selective culture, and incubating the selective culture over a sufficiently long period of time, to allow only the group of microorganisms for which the culture medium exhibits favorable growth conditions the opportunity to multiply, in association with metabolic products, in particular CO.sub.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: August 4, 1998
    Assignee: Beiersdorf AG
    Inventors: Bianca Mayer, Gerhard Sauermann, Bernd Traupe, Florian Wolf
  • Patent number: 5763169
    Abstract: Nucleic acid probes and primers are described for detecting fungi that cause disease in humans and animals, as well as spoilage of food and beverages. These probes can detect rRNA, rDNA or polymerase chain reaction products from a majority of fungi in clinical, environmental or food samples. Nucleic acid hybridization assay probes specific for Aspergillus fumigatus, Blastomyces dermatitidis, Candida albicans, Coccidioides immitis, Cryptococcus neoformans, Histoplasma capsulatum, Aspergillus flavus, Aspergillus glaucus, Aspergillus niger, Aspergillus terreus, Candida glabrata, Candida guilliermondii, Candida kefyr, Candida krusei, Candida lusitaniae, Candida parapsilosis, Candida tropicalis, Pseudallescheria boydii, and Sporothrix schenckii are also described.
    Type: Grant
    Filed: January 13, 1995
    Date of Patent: June 9, 1998
    Assignee: Chiron Diagnostics Corporation
    Inventors: Gurpreet S. Sandhu, Bruce C. Kline
  • Patent number: 5756321
    Abstract: Methods for the enzyme catalyzed acylation of primary and secondary alcohols using an enol ester as the acyl donor are described. The acylation occurs in organic media, and is enantioselective for racemic or prochiral alcohols. The reaction is irreversible, and produces unreactive by-products.
    Type: Grant
    Filed: February 20, 1996
    Date of Patent: May 26, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Manfred Schudok, Gerhard Kretzschmar
  • Patent number: 5741662
    Abstract: The present invention provides specific binding solid phase assay methods and kits for the detection of the presence or absence of a microorganism by directly staining the microorganism and specifically capturing the stained microorganism on a solid support. The methods find particular utility in the detection of Candida. The methods may simultaneously detect the presence or absence of multiple microorganisms.
    Type: Grant
    Filed: December 18, 1995
    Date of Patent: April 21, 1998
    Assignee: Quidel Corporation
    Inventors: Randall D. Madsen, Lorraine S. Bautista, Jan W. Pawlak, Allan D. Pronovost
  • Patent number: 5707802
    Abstract: Nucleic acid probes and primers are described for detecting fungi that cause disease in humans and animals, as well as spoilage of food and beverages. These probes can detect rRNA, rDNA or polymerase chain reaction products from a majority of fungi in clinical, environmental or food samples. Nucleic acid hybridization assay probes specific for Acremonium sp., Aspergillus clavatus, Aspergillus flavus, Aspergillus fumigatus, Aspergillus glaucus, Aspergillus nidulans, Aspergillus niger, Aspergillus ochraceus, Aspergillus terreus, Aspergillus unguis, Aspergillus ustus, Beauveria sp., Bipolaris sp., Blastoschizomyces sp., Blastomyces dermatitidis, Candida albicans, Candida glabrata, Candida guilliermondii, Candida kefyr, Candida krusei, Candida lusitaniae, Candida parapsilosis, Candida tropicalis, Chrysosporium sp., Cladosporium sp., Coccidioides immitis, Cryptococcus neoformans var gattii serotype B, Cryptococcus neoformans serotype A, Cryptococcus laurentii, Cryptococcus terreus, Curvularia sp., Fusarium sp.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: January 13, 1998
    Assignee: Ciba Corning Diagnostics Corp.
    Inventors: Gurpreet S. Sandhu, Bruce C. Kline
  • Patent number: 5686248
    Abstract: A polypeptide sequence from Candida albicans is described which has significant sequence homology with known stress proteins from other organisms, particularly the heat shock protein hsp 90 of Saccharomyces cerevisiae. Corresponding DNA sequences are also described, together with antibodies raised against fragments of the sequence. The polypeptide and DNA sequences and antibodies provide separate means for the diagnosis and/or treatment of fungal, particularly Candida, infections.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: November 11, 1997
    Assignee: The Victoria University of Manchester
    Inventors: James Peter Burnie, Ruth Christine Matthews
  • Patent number: 5658726
    Abstract: A method for constructing a cDNA probe for use in detecting in a sample, under conditions of predetermined stringency, a target organism belonging to a strain of fungal microorganisms, and not detecting in the sample under such conditions a reference microorganism or any prokaryotic microorganism, includes the steps of determining a nucleotide base sequence in a variable region of small subunit ribosomal RNA from the target organism, the variable region being a region of the small subunit ribosomal RNA that is poorly conserved among eukaryotes and having no corresponding region in prokaryotes; comparing the nucleotide base sequence in the corresponding region of small subunit ribosomal RNA from the reference microorganism, and selecting as a useful probe site a subsequence within the determined sequence; and synthesizing a cDNA complementary to the useful probe site, the cDNA being the probe. Nucleic acid probes are constructed according to the disclosed method.
    Type: Grant
    Filed: March 27, 1992
    Date of Patent: August 19, 1997
    Assignee: Amoco Corporation
    Inventor: Jeffrey F. Lemontt
  • Patent number: 5604119
    Abstract: The present invention relates to a process for preparing a triglyceride, comprising reacting glycerol with a polyunsaturated fatty acid having at least 20 carbon atoms and at least three double bonds or a C.sub.1-4 alkyl ester thereof, for a reaction time in the range of 24-48 hours at a temperature between 40.degree. and 80.degree. C. in the presence of a mixture of lipase A and lipase B obtained from Candida antarctica which is immobilized, to form (i) the triglyceride and (ii) water or a C.sub.1-4 alcohol, while removing the water or the C.sub.1-4 alcohol during the reaction, and recovering the triglyceride.
    Type: Grant
    Filed: January 23, 1995
    Date of Patent: February 18, 1997
    Assignees: Novo Nordisk A/S, LYSI HF
    Inventors: Gudmundur G. Haraldsson, Hanne Svanholm, Baldur Hjaltason
  • Patent number: 5449612
    Abstract: The present invention relates to a method of determining, assaying and identifying strains of Candida and pathogenic strains belonging to species Torulopsis glabrata by means of chromogenic substrates of monoamino acid or peptide type without the isolation of the strains to be identified.
    Type: Grant
    Filed: November 19, 1991
    Date of Patent: September 12, 1995
    Assignee: Serbio
    Inventors: Jean-Pierre Lepargneur, Genevieve Contant epouse Pussard, Jean-Luc Martinoli, Gerard Quentin
  • Patent number: 5405745
    Abstract: Isolated nucleic acid molecules capable of hybridizing to sequences of Candida albicans along with methods utilizing such probes for the detection of Candida albicans in clinical and other biological samples.
    Type: Grant
    Filed: December 17, 1991
    Date of Patent: April 11, 1995
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Jessica A. Gorman, Catherine A. Bingham
  • Patent number: 5374423
    Abstract: Cytokine receptors for tumor necrosis factor e which are found on microorganisms may, if bound with exogenous TNF.alpha., enhance the response of natural killer cells activated by the microorganisms, or increase TNF.alpha. production by peripheral blood lymphocytes treated with the microorganisms. Microorganisms with receptor-bound exogenous TNF.alpha. have enhanced cellular invasion ability which may change the immune response thereto. Clinical and pharmaceutical applications of these discoveries are provided.
    Type: Grant
    Filed: August 27, 1993
    Date of Patent: December 20, 1994
    Assignee: Board of Regents, The University of Texas System
    Inventors: Gary R. Klimpel, David W. Niesel
  • Patent number: 5294546
    Abstract: A method of producing a growth promoting factor for Bifidobacterium species from lactose which comprises contacting lactose with resting cells of a lactose-utilizing yeast strain having activity to rearrange lactose to galacto-oligosaccharides.
    Type: Grant
    Filed: November 29, 1991
    Date of Patent: March 15, 1994
    Assignee: Unitika Ltd.
    Inventors: Munehiko Dombou, Isao Tomioka, Ryoichi Tsurutani, Senji Kitabatake, Hiroshi Nakajima
  • Patent number: 5288639
    Abstract: A polypeptide sequence from Candida albicans is described which has significant sequence homology with known stress proteins from other organisms, particularly the heat shock protein hsp 90 of Sacchromyces cerevisiae. Corresponding DNA sequences are also described, together with antibodies raised against fragments of the sequence. The polypeptide and DNA sequences and antibodies provide separate means for the diagnosis and/or treatment of fungal, particularly Candida, infections.
    Type: Grant
    Filed: March 14, 1991
    Date of Patent: February 22, 1994
    Assignee: The Victoria University of Manchester
    Inventors: James P. Burnie, Ruth C. Matthews
  • Patent number: 5270038
    Abstract: Cytokine receptors for tumor necrosis factor .alpha. which are found on microorganisms may, if bound with exogenous TNF.alpha., enhance the response of natural killer cells activated by the microorganisms, or increase TNF.alpha. production by peripheral blood lymphocytes treated with the microorganisms. Microorganisms with receptor-bound exogenous TNF.alpha. have enhanced cellular invasion ability which may change the immune response thereto. Clinical and pharmaceutical applications of these discoveries including vaccines with increased efficacy are provided.
    Type: Grant
    Filed: January 23, 1992
    Date of Patent: December 14, 1993
    Assignee: Board of Regents, The University of Texas System
    Inventors: Gary R. Klimpel, David W. Niesel
  • Patent number: 5081033
    Abstract: Methods and compositions are disclosed for the rapid identification of fungal pathogens. In a preferred method, a sample of human body fluid is obtained and subjected to analysis comprising inoculating a nutritive medium, incubating said inoculum for such time and temperature as is necessary for visible fungal colony formation, thereafter plating a sample of said visible fungi on miniature culture plates for example having the dimensions of about 33.times.75.times.5 millimeters, said plates containing differential fungal media, and thereafter identifying funal pathogens in a manner consistent with said medium selected.
    Type: Grant
    Filed: July 14, 1986
    Date of Patent: January 14, 1992
    Assignee: Wadley Technologies, Inc.
    Inventors: Gordon L. Dorn, William H. Fleming, Karen L. Knezek
  • Patent number: 5077206
    Abstract: The invention provides a process for preparing L-rhamnose by hydrolyzing a rhamnosidic bond of a glycoside having rhamnose in a terminal position, by enzymatically hydrolyzing the glucoside with an enzyme combination comprising biological structural material degrading enzyme and a naringinase preparation which has a higher rhamnosidase activity than beta-glucosidase activity. Preferably the enzyme combination having rhamnosidase activity together with additional enzyme activity is a selected partially purified enzyme preparation having high rhamnosidase activity and low glucosidase activity together with biological structural material degrading activity. More preferably the additional enzyme activity is derived from an enzyme of the group consisting of protease, lipase, pectinase, cellulase and hemicellulase.
    Type: Grant
    Filed: November 21, 1988
    Date of Patent: December 31, 1991
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Peter S. J. Cheetham, Michael A. Quail
  • Patent number: 4981794
    Abstract: A method is provided for preparing D(-)-.beta.-hydroxyisobutyric acid by fermentation employing the method and/or ethyl esters of isobutyric acid, the methyl and/or ethyl esters of methacrylic acid, isobutyl isobutyrate and/or isobutyl methacrylate as the substrate and a microorganism of the genus Candida and other fungi. In an alternative method, the isolated cells of the various microorganisms are employed with one or mixtures of the above substrates.
    Type: Grant
    Filed: October 19, 1987
    Date of Patent: January 1, 1991
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Robert S. Robison, Laszlo J. Szarka
  • Patent number: 4874695
    Abstract: Rapid identification of different species of microorganism selected from fungi and yeast like algae is accomplished by culturing the microorganism for several hours under normal conditions on a non-inhibitory mycological medium which stimulates the microorganism to make characteristic enzymes by which the microorganism can be identified, distributing the culture (in suspension) onto several supports containing different substrates which are capable of reacting with the enzymes so produced by the different species of microorganisms; and rapidly incubating the admixture to produce a distinctly colored or colorable reaction product.
    Type: Grant
    Filed: February 21, 1985
    Date of Patent: October 17, 1989
    Assignee: American Home Products Corp.
    Inventor: David H. Pincus
  • Patent number: 4847128
    Abstract: Methods and compositions are disclosed for the rapid identification of fungal pathogens. In a preferred method, a sample of human body fluid is obtained and subjected to analysis comprising inoculating a nutritive medium, incubating said inoculum for such time and temperature as is necessary for visible fungal colony formation, thereafter plating a sample of said visible fungi on miniature culture plates for example having the dimensions of about 33.times.75.times.5 millimeters, said plates containing differential fungal media, and thereafter identifying fungal pathogens in a manner consistent with said medium selected.
    Type: Grant
    Filed: July 14, 1986
    Date of Patent: July 11, 1989
    Assignee: Wadley Technologies, Inc.
    Inventors: Gordon L. Dorn, William H. Fleming, Karen L. Knezek
  • Patent number: 4735901
    Abstract: Candida albicans has been transformed by the insertion of a plasmid comprising a fragment of DNA from Candida albicans containing the intact ADE 2 gene.
    Type: Grant
    Filed: January 14, 1985
    Date of Patent: April 5, 1988
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Myra B. Kurtz, Donald R. Kirsch
  • Patent number: 4379841
    Abstract: The disclosure relates to a culture medium containing as a sole carbon source 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid or a mixture thereof, and to an assimilation test for identifying yeasts utilizing such a culture medium.
    Type: Grant
    Filed: October 2, 1981
    Date of Patent: April 12, 1983
    Assignee: Abbott Laboratories
    Inventor: Billy H. Cooper
  • Patent number: 4182753
    Abstract: A Sarcoma 180 tumor growth inhibiting glycoprotein material produced extracellularly from Candida albicans is provided. The inhibitor material is effective to arrest Sarcoma 180 tumor angiogenesis thereby causing tumor regression. The preferred inhibitor material is an extracellular glycoprotein produced from Candida albicans SA#1 (CBS 5736) cultured in a glucose containing chemical medium with a filtrate of the growth medium precipitated with ethanol. Dosage innoculations of the precipitate into the peritoneal cavities of Sarcoma 180 tumor infected mice effect substantial tumor regression.
    Type: Grant
    Filed: March 29, 1978
    Date of Patent: January 8, 1980
    Inventor: Cora G. Saltarelli